Viewing Study NCT07264634


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-05-17 @ 5:30 AM
Study NCT ID: NCT07264634
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
Sponsor: Ascendis Pharma A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypoparathyroidism View
Keywords: